Latest Insider Transactions at Fennec Pharmaceuticals Inc. (FENC)
This section provides a real-time view of insider transactions for Fennec Pharmaceuticals Inc. (FENC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FENNEC PHARMACEUTICALS INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FENNEC PHARMACEUTICALS INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2023
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
3,144
+6.37%
|
$3,144
$1.59 P/Share
|
|
Dec 26
2023
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,390
-3.01%
|
$13,900
$10.9 P/Share
|
|
Nov 20
2023
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
269
-0.62%
|
$2,152
$8.25 P/Share
|
|
Nov 16
2023
|
Khalid Islam |
BUY
Exercise of conversion of derivative security
|
Direct |
213,825
+21.45%
|
$427,650
$2.14 P/Share
|
|
Nov 08
2023
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
25,044
-4.15%
|
$175,308
$7.8 P/Share
|
|
Nov 03
2023
|
Rosty Raykov |
BUY
Exercise of conversion of derivative security
|
Direct |
74,793
+19.56%
|
$74,793
$1.59 P/Share
|
|
Aug 18
2023
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
673
-1.53%
|
$4,711
$7.85 P/Share
|
|
Jul 24
2023
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
6,796
-13.39%
|
$54,368
$8.17 P/Share
|
|
Jul 24
2023
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+24.71%
|
$0
$0.72 P/Share
|
|
Jul 06
2023
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
5,280
+13.41%
|
$0
$0.96 P/Share
|
|
Jul 06
2023
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
2,207
-7.11%
|
$17,656
$8.47 P/Share
|
|
Jun 30
2023
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+14.31%
|
$50,000
$2.45 P/Share
|
|
Jun 30
2023
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-5.67%
|
$60,000
$8.82 P/Share
|
|
Jun 29
2023
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-5.37%
|
$60,000
$8.97 P/Share
|
|
Jun 28
2023
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-6.68%
|
$80,000
$8.99 P/Share
|
|
May 19
2023
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,758
-2.72%
|
$12,306
$7.36 P/Share
|
|
Apr 17
2023
|
Chris A Rallis |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-2.92%
|
$7,888
$8.34 P/Share
|
|
Apr 17
2023
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
1,700
+4.79%
|
$3,400
$2.94 P/Share
|
|
Mar 03
2023
|
Chris A Rallis |
SELL
Payment of exercise price or tax liability
|
Direct |
2,177
-6.36%
|
$19,593
$9.09 P/Share
|
|
Mar 03
2023
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+10.86%
|
$8,332
$2.4 P/Share
|
|
Dec 30
2022
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-2.21%
|
$90,000
$9.64 P/Share
|
|
Dec 30
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,500
-3.54%
|
$49,500
$9.61 P/Share
|
|
Dec 29
2022
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
5,000
-2.15%
|
$45,000
$9.65 P/Share
|
|
Dec 29
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,500
-3.42%
|
$49,500
$9.57 P/Share
|
|
Dec 28
2022
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
13,740
-5.57%
|
$123,660
$9.59 P/Share
|
|
Dec 28
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,000
-6.41%
|
$99,000
$9.61 P/Share
|
|
Nov 17
2022
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
333
-1.1%
|
$2,331
$7.99 P/Share
|
|
Oct 20
2022
|
Chris A Rallis |
SELL
Payment of exercise price or tax liability
|
Direct |
2,068
-6.38%
|
$16,544
$8.26 P/Share
|
|
Oct 20
2022
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
4,762
+12.81%
|
$4,762
$1.05 P/Share
|
|
Sep 21
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19,052
-9.99%
|
$152,416
$8.54 P/Share
|
|
Sep 21
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+16.43%
|
-
|
|
Jul 18
2022
|
Chris A Rallis |
SELL
Payment of exercise price or tax liability
|
Direct |
4,379
-13.67%
|
$26,274
$6.7 P/Share
|
|
Jul 18
2022
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
11,111
+25.75%
|
$0
$0.45 P/Share
|
|
Mar 08
2022
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
17,592
+36.17%
|
$0
$0.57 P/Share
|
|
Oct 21
2021
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
$3,333
$1.5 P/Share
|
|
May 04
2020
|
Southpoint Capital Advisors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+1.92%
|
$480,000
$6.25 P/Share
|